Pikovit D

Country: Armenia

Language: English

Source: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

Active ingredient:

vitamin A, vitamin D3, vitamin C, nicotinamide, calcium pantotenate, vitamin B2, vitamin B6, vitamin B1, folic acid, vitamin B12, calcium, phosphorus

Available from:

KRKA d.d.

INN (International Name):

vitamin A, vitamin D3, vitamin C, nicotinamide, calcium pantotenate, vitamin B2, vitamin B6, vitamin B1, folic acid, vitamin B12

Dosage:

600IU+80IU+10mg+3mg+1,20mg+0,3mg+0,3mg+0,25mg+0,04mg+0,2mcg+12,5mg+10mg

Pharmaceutical form:

lozenges

Prescription type:

OTC

Summary of Product characteristics

1.3.1
Pikovit D
SPC, Labeling and Package Leaflet
SmPCPIL070689_3
19.02.2016 – Updated: 12.04.2016
Page 1 of 6
1.
NAME OF THE MEDICINAL PRODUCT
Pikovit D lozenges
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains:
-
600 IU of vitamin A (retinolum) as retinyl palmitate,
-
80 IU of cholecalciferol (cholecalciferolum, vitamin D
3
),
-
10 mg of ascorbic acid (acidum ascorbicum, vitamin C),
-
0.25 mg of thiamine nitrate (thiamini nitras, vitamin B
1
),
-
0.30 mg of riboflavin (riboflavinum, vitamin B
2
),
-
0.30 mg of pyridoxine hydrochloride (pyridoxini hydrochloridum,
vitamin B
6
),
-
0.20 µg of cyanocobalamin (cyanocobalaminum, vitamin B
12
),
-
3 mg of nicotinamide (nicotinamidum),
-
1.2 mg of calcium pantothenate (calcii pantothenas),
-
0.04 mg of folic acid (acidum folicum),
-
12.5 mg of calcium (calcium) as anhydrous calcium hydrogen phosphate,
-
10 mg of phosphorus (phosphorus) as anhydrous calcium hydrogen
phosphate.
Excipients:
-
maltitol (E965): 449.18 mg/tablet
-
liquid maltitol: 461.00 mg/tablet
For a full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Lozenges.
The tablets are round, biconvex, yellow, orange, green and red.
4.
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Pikovit D lozenges are intended for the prevention of vitamin and
mineral deficiency mainly for
children:
-
to enhance body's resistance to infections and during colds,
-
in the convalescence period after illness,
-
in increased physical and mental strains,
-
in excessive tiredness in school children,
-
in decreased appetite,
-
in irregular and inadequate diet,
-
as an adjunct after antibiotic therapy.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
Children from 4 to 6 years of age: 1 lozenge 4 to 5 times a day.
Children from 7 to 14 years of age: 1
lozenge 5 times to7 times daily.
Children should dissolve Pikovit D lozenges in the mouth.
1.3.1
Pikovit D
SPC, Labeling and Package Leaflet
SmPCPIL070689_3
19.02.2016 – Updated: 12.04.2016
Page 2 of 6
4.3
CONTRAINDICATIONS
-
hypersensitivity to the active subs